NOG and osteosarcoma: Taken together, we revealed for the first time that Noggin enhances phosphorylation of FGFR2 in both adipose-derived stem cells and osteosarcoma-derived osteoblastic cells and activates FGFR2/Src/Akt and ERK intracellular signaling pathway in adipose-derived stem cells.